Fig. 4.

Relationship between occurrence of minor bleeding complication and Morisky medication adherence in non-valvular atrial fibrillation patients treated with dabigatran (no bleeding complication n = 153, minor bleeding complication n = 22, exclusion major bleeding n = 0), rivaroxaban (no bleeding complication n = 124, minor bleeding complication n = 73, exclusion major bleeding n = 1) or apixaban (no bleeding complication n = 139, minor bleeding complication n = 55, exclusion major bleeding n = 2). The occurrence of minor bleeding complication was not associated with lower degree of adherence in patients treating with dabigatran, rivaroxaban or apixaban